Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Miralles Gines Diego received 45,000 Artiva Biotherapeutics, Inc. shares as an award (Form 4)
Traded Sep 9, 2026 · Filed Sep 11, 2026
On Sep 9, 2026, Miralles Gines Diego (President & Head of R&D) received 45,000 Artiva Biotherapeutics, Inc. shares as an award, leaving 122,500 shares. Filed Sep 11, 2026 (Form 4).
- Awarded
- 45,000 shares
- Holding after
- 122,500 shares
- Trading plan
- No
- Role
- President & Head of R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Common Stock | Award | 45,000 | 122,500 | Direct |
Source
Related
- Artiva Biotherapeutics, Inc.
- Miralles Gines Diego
- Artiva Biotherapeutics, Inc. shareholders
- Form 4 · Miralles Gines Diego · May 19, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026